Filing Details
- Accession Number:
- 0000880984-22-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-15 19:40:31
- Reporting Period:
- 2022-11-11
- Accepted Time:
- 2022-11-15 19:40:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1719406 | Nrx Pharmaceuticals Inc. | NRXP | Pharmaceutical Preparations (2834) | 822844431 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864534 | C. Daniel Javitt | 1201 North Market Street Suite 111 Wilmington DE 19801 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-11 | 49,200 | $1.01 | 9,823,701 | No | 4 | S | Indirect | by Glytech LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Glytech LLC |
Footnotes
- Sale was pursuant to the terms of a 10b5-1 trading plan established on June 13, 2022.
- Held by Glytech LLC of which the Reporting Person is the sole owner.
Billionaire Hedge Funds
